We first studied the association of ZBTB12 methylation factors with a number of classical CVD risk factors, including physical activity, smoke, hypertension, dyslipidemia, obesity, diabetes, and alcohol consumption. Here, ZBTB12 is linked to obesity due to melanocortin 4 receptor deficiency.